Progressive Care (RXMD) 0.0080 $RXMD Progressive Care

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Progressive Care (RXMD) 0.0080 $RXMD

Progressive Care Closes October With Strong Year-Over-Year Performance
Marketwired - Tue Nov 17, 7:07AM CST
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces strong October sales.

Progressive Care: PharmCo, LLC Delivers Fourth Consecutive Quarter of Profitability
Marketwired - Tue Nov 10, 7:23AM CST
Progressive Care Inc., through its subsidiary PharmCo LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces four consecutive quarters of profitability for PharmCo, LLC.

Penny Stocks Roundup for GLOBAL DIGITAL SOLTN, Max Sound, Cellceutix, Peregrine Pharmaceuticals, Progressive Care, and 3D EYE SOLUTIONS
PR Newswire - Thu Oct 29, 8:00AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: GLOBAL DIGITAL SOLTN (OTCMKTS:GDSI), Max Sound (OTCBB:MAXD), Cellceutix (OTCMKTS:CTIX), Peregrine Pharmaceuticals (NASDAQPHM), Progressive Care (OTCMKTS:RXMD), and 3D EYE SOLUTIONS (OTCMKTS:TDEY).
PPHM: 1.12 (unch)

Progressive Care's Strong Third Quarter Brings Revenues to $10 Million
Marketwired - Tue Oct 13, 7:03AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces fourth consecutive month of record prescription sales.

Progressive Care Issues Update on 3(a)(10) Transaction
Marketwired - Wed Sep 16, 7:02AM CDT
Progressive Care Inc. (OTC PINK: RXMD) (the "Company", through its subsidiary Pharmco LLC, is a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment and the supply of prescription medications to long term care facilities, issues an update on the progress of the ongoing 3(a)(10) transaction.

Progressive Care Continues Record Breaking Run in August
Marketwired - Thu Sep 10, 7:02AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces another month of record prescription sales for August 2015.

Progressive Care Announces Record Prescription Sales for July 2015
Marketwired - Wed Aug 19, 7:01AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces record prescription sales for July 2015.

Analyst Coverage Initiated on Progressive Care, Inc. (RXMD) with Speculative Buy Rating Following Recent Earnings Announcement
PR Newswire - Wed Aug 12, 6:45AM CDT
In the last month of 2014, Progressive Care, Inc. (RXMD) through its subsidiary PharmCo, LLC, filled over 14,000 prescriptions as the number of prescriptions filled rose for a 6th straight month. During the three months ended June 30, 2015, prescriptions counts reached a record high of approximately 43,000 fills, which represents a year-over-year increase of 11%. Most recently on August 6, 2015, Progressive Care reported a net revenue increase of 18% year-over-year for the six months ended June 30, 2015 from approximately $5.40 million to approximately $6.40 million. This significant improvement in operating performance was a result of higher gross margins associated with compounded medications and a more efficient operational structure. Cash position has also improved with cash on hand increasing $282,486 from the beginning of the year.

Progressive Care Achieves Operating Profits After Record Sales Quarter
Marketwired - Thu Aug 06, 7:01AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, releases quarterly report today recording its first operational profit since 2010.

Progressive Care Enters $10 Billion 340B Market
Marketwired - Mon Jul 20, 7:01AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces 340B contract with Empower "U".

Progressive Care Sets New Sales Record During Second Quarter 2015
Marketwired - Thu Jul 09, 7:02AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces record pharmacy sales for June 2015.

Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products Continue to Hit the Market - Company Prepares for Strong Revenue Growth in 2nd Half of 2015
PR Newswire - Mon Jun 29, 9:27AM CDT
One of the fastest growing industries in the world is the nutritional supplement group, or more broadly known as Vitamins, Minerals and Supplements. It is projected that the industry may top $60 billion in 2021 according to the Nutritional Business Journal. Nutritional Supplement Companies, Retailers and Pharmaceutical Operations in focus today are Axxess Pharma Inc. (OTC: AXXE), Progressive Care Inc. (OTC: RXMD), USANA Health Sciences Inc. (NYSE: USNA), GNC Holdings Inc. (NYSE: GNC) and ARCA biopharma, Inc. (NASDAQ: ABIO)
OPK: 10.75 (+0.12), WWE: 16.66 (-0.08), GNC: 27.14 (-3.91), ABIO: 5.08 (+0.03), USNA: 122.23 (-1.40), RAD: 7.76 (+0.02)

Summers Small Cap Stock Portfolio
ACCESSWIRE - Fri Jun 26, 6:30AM CDT
CORAL GABLES, FL / ACCESSWIRE / June 26, 2015 / Continued overhang from the crisis in Greece continue to weigh down the larger markets. In the larger markets, the standstill to finalize decisions has negatively affected many companies trading on the NYSE and NASDAQ. One segment not seeing any kind of consolidation has been the market that is trading penny stocks. Tens, hundreds, and even thousands of percentage points have been realized during a time of financial turmoil overseas. Despite these dealings, small and micro cap stocks have surged during the early parts of the summer months. Progressive Care, Inc. (OTC:RXMD), Enviro-Serv, Inc. (OTC:EVSV), and RXi Pharmaceuticals Corporation (NASDAQ:RXII) have also seen price as well as volume trend above average.
RXII: 0.38 (-0.02)

Progressive Care Announces Record Pharmacy Revenues for May 2015
Marketwired - Thu Jun 25, 7:02AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces record pharmacy revenues for May 2015.

Progressive Care Revenues Increase 17% and Reach Near Operating Profitability
Marketwired - Thu May 21, 12:37PM CDT
Progressive Care Inc., through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, releases annual report today recording over $3 million in sales revenue for the first quarter of 2015.

Progressive Care: PharmCo Supports 27th Annual Miami AIDS Walk
Marketwired - Mon Apr 27, 11:46AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, participated in the 27th Annual Miami AIDS Walk.

Progressive Care Reaches Over $11 Million in Revenues in 2014
Marketwired - Wed Apr 15, 8:33AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, released its annual report today recording over $11 million in sales revenue for fiscal year 2014.

Progressive Care Announces Alliance With Vet Power, LLC
Marketwired - Mon Mar 30, 8:03AM CDT
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary PharmCo LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announced today that in a joint effort with Vet Power, the companies will be designing a plan to educate members participating in the TRICARE Health Plan. The education plan will focus on compounded medication coverage.

Progressive Care Announces Alliance With Health Care of South Florida to Launch Medication Monitoring and Health Safety Program
Marketwired - Tue Jan 27, 8:30AM CST
Progressive Care Inc. (OTC PINK: RXMD) ("Progressive" or the "Company", a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME" and the supply of prescription medications to long term care facilities, announces new medication monitoring and health safety program with Health Care of South Florida.

Mid-Day Volume Actives: Are These The Stocks You're Trading Today?
PR Newswire - Thu Jan 22, 1:15PM CST
Today the key indices are holding strong around their highs. The Dow is up just a hair at half a percent and both the S & P and Nasdaq have been approaching 1% highs during the morning session. The recent State of the Union has Americans mixed but one thing is certain, the stock market continues to reflect the "January Effect":

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 134

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 231

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 113

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 98

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 203

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 163

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 204

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Haven Tower Elevates Leaders for Strategic Expansion

Updated Category News Views 6

When a company starts moving its chess pieces around, savvy investors know it's time to pay attention. Haven Tower Group, a heavyweight in strategic communications for the wealth management realm, is shaking things up. They've promoted Mitch Manning to Chief Engagement Officer & Partner and brought on Grant Cox as Principal. These moves aren't just about office...

Continue Reading
CoStar Group Set to Release Q4 and Full Year 2024 Results

Updated Category News Views 205

CoStar Group Plans to Announce Financial Outcomes CoStar Group, Inc. (NASDAQ: CSGP), a prominent leader in online real estate marketplaces and analytics, is gearing up to present its financial results for the fourth quarter and the entirety of the 2024 fiscal year. The announcement will take place following the market's closing on a specified Tuesday, during which...

Continue Reading
Disc Medicine's Participation in Key Investor Conferences

Updated Category News Views 97

Disc Medicine to Participate in Key Investor Conferences Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, is setting the stage for crucial engagements with investors. The company focuses on the discovery, development, and commercialization of innovative treatments aimed at patients facing serious hematologic...

Continue Reading
Bollinger Motors Celebrates First B4 Truck Deliveries Ahead

Updated Category News Views 50

Bollinger Motors delivered its first B4 electric trucks to Nacarato Truck Centers back in September 2024, marking an important step in their operational journey. This deal was worth a solid $800,000—a number that certainly turned heads among desks tracking EV trends. The delivery set the stage for what traders hoped would be a stream of revenue as Bollinger established...

Continue Reading
Nasdaq Achieves Significant Growth and Future Predictions

Updated Category News Views 191

Revenue Highlights from Nasdaq's Latest Report Nasdaq, Inc. (NASDAQ:NDAQ) recently revealed impressive financial results, showcasing a remarkable revenue increase of 15% compared to the previous year, totaling $1.315 billion. This was a better outcome than analysts had anticipated, with expectations set at $1.297 billion. Strong Adjusted Earnings The financial services...

Continue Reading